Literature DB >> 9015323

Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy.

Z Maglóczky1, P Halász, J Vajda, S Czirják, T F Freund.   

Abstract

The loss of the calcium binding protein, Calbindin-D28k, from dentate granule cells has been observed in different animal models of epilepsy and in ischaemia. This decrease is accompanied by alterations of calcium and N-methyl-D-aspartate currents, which may explain the hyperexcitability of the dentate gyrus. In the present study, we found a loss of calbindin immunoreactivity from over 90% of the dentate granule cells in lobectomy samples from four of 10 temporal lobe epilepsy patients. In another four patients, over 50%, of dentate granule cells were devoid of calbindin immunoreactivity, whereas the remaining two cases showed a 20-30% decrease. Electron microscopy revealed a normal ultrastructure both in calbindin-containing and calbindin-negative granule cells. Both calbindin-positive and -negative mossy fibre collaterals participated in supragranular sprouting. As inferred from data in animal models, the lack of calbindin in dentate granule cells of human epileptic subjects is likely to result in hyperexcitability of the dentate gyrus, which may then function as a "motor" for seizures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015323     DOI: 10.1016/s0306-4522(96)00440-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  34 in total

1.  Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis.

Authors:  H E Scharfman; J H Goodman; A L Sollas
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Ectopic granule cells of the rat dentate gyrus.

Authors:  Helen Scharfman; Jeffrey Goodman; Daniel McCloskey
Journal:  Dev Neurosci       Date:  2007       Impact factor: 2.984

Review 3.  Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis.

Authors:  Nisha Nagarkatti; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Expert Rev Neurother       Date:  2009-06       Impact factor: 4.618

4.  GABA(B) receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy.

Authors:  A Billinton; V H Baird; M Thom; J S Duncan; N Upton; N G Bowery
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Surviving granule cells of the sclerotic human hippocampus have reduced Ca(2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy.

Authors:  U V Nägerl; I Mody; M Jeub; A A Lie; C E Elger; H Beck
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

6.  Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans.

Authors:  Zsófia Maglóczky; Kinga Tóth; Rita Karlócai; Sára Nagy; Loránd Eross; Sándor Czirják; János Vajda; György Rásonyi; Anna Kelemen; Vera Juhos; Péter Halász; Ken Mackie; Tamás F Freund
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

7.  Compensatory regulation of Cav2.1 Ca2+ channels in cerebellar Purkinje neurons lacking parvalbumin and calbindin D-28k.

Authors:  Lisa Kreiner; Carl J Christel; Morris Benveniste; Beat Schwaller; Amy Lee
Journal:  J Neurophysiol       Date:  2009-11-11       Impact factor: 2.714

Review 8.  GABA-ergic cell therapy for epilepsy: Advances, limitations and challenges.

Authors:  Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2015-12-31       Impact factor: 8.989

9.  Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Muddanna S Rao; Ashok K Shetty
Journal:  Exp Neurol       Date:  2008-05-15       Impact factor: 5.330

Review 10.  Potassium Channels in Epilepsy.

Authors:  Rüdiger Köhling; Jakob Wolfart
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.